Introduction: Professional workers that manufacture or use titanium dioxide (TiO 2 )-based paints are exposed to potentially toxic TiO 2 nanomaterials as well as to different paint solvents such as dimethyl sulfoxide (DMSO). In this context, we evaluate the combined cytotoxic effects of TiO 2 nanoparticles and DMSO on HepG 2 human hepatocytes.Methods: Three types of TiO 2 nanoparticles were used: commercial Degussa P25 and two samples synthesized by a hydrothermal procedure -undoped and Fe 3+ -doped TiO 2 . The effects of TiO 2 nanoparticles on HepG2 cells exposed to DMSO before, after or together with the TiO 2 treatment were investigated by viability and intracellular reactive oxygen species (ROS) determinations, performed using the MTT and DCFH-DA(2',7'-dichlorfluorescein-diacetate) methods respectively.
Results:Results indicated that DMSO made HepG2 cells more susceptible to toxic effects induced by nanosized TiO 2 . In the absence of DMSO, none of the tested nanoparticles exhibited significant cytotoxic effects. Viability increases were detected after 48 hours of treatment and attributed to possible redox-sensitive proliferation mechanism striggered by the low and moderate amounts of produced ROS. The combined action of TiO 2 and DMSO led to a general viability decrease tendency. Significant effects (viability reductions and ROS generation) were observed in the case of cells first treated with Degussa P25 TiO 2 and afterwards exposed to DMSO. The hydrothermal materials exhibited reduced in vitro reactivity on HepG 2 hepatocytes.
Conclusion:The study reveals the enhancement of nanosized TiO 2 toxicity induced by DMSO exposure, its findings having potential to help in the evaluation of professional health risks associated to the combined action of TiO 2 nanomaterials and paint solvents.